Eli Lilly Earnings Beat, GLP-1 Sales Miss
This is a LLY news story, published by Yahoo Finance, that relates primarily to Zepbound news.
LLY news
For more LLY news, you can click here:
more LLY newsZepbound news
For more Zepbound news, you can click here:
more Zepbound newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
big pharma companies. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest obesity drug company news, FDA drug shortage list news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
pharma giantYahoo Finance
•Health
Health
Eli Lilly reports mixed earnings, increases 2025 guidance

88% Informative
Eli Lilly ( LLY ) reported fourth quarter and full year earnings for 2024 Thursday .
Results largely beat Wall Street estimates and sent its stock up about 2% in pre-market trading.
But the company missed on GLP-1 sales, with sales of Mounjaro for diabetes and Zepbound for weight loss.
For the full year , Lilly reported $45 billion in revenue.
VR Score
91
Informative language
90
Neutral language
85
Article tone
formal
Language
English
Language complexity
43
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
3
Affiliate links
no affiliate links